Evidence map›Paper›PMID 39095680›Full record

ArticleAnnals of clinical and translational neurology2024

True first-pass effect in patients undergoing thrombectomy for acute large core strokes.

Shitao Fan, Changwei Guo, Jiacheng Huang, Zhouzhou Peng, Chengsong Yue, Jie Yang, Linyu Li, Dongjing Xie, Nizhen Yu, Shihai Yang and 4 more

Abstract readMulticenter Study
In one paragraph

Article in Annals of clinical and translational neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Shitao FanDepartment of Neurology, Xinqiao Hospital and the Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.ORCID 0009-0007-7179-859X
Changwei GuoDepartment of Neurology, Xinqiao Hospital and the Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Jiacheng HuangDepartment of Neurology, Xinqiao Hospital and the Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.ORCID 0000-0002-6962-7253
Zhouzhou PengDepartment of Neurology, Xinqiao Hospital and the Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Chengsong YueDepartment of Neurology, Xinqiao Hospital and the Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Jie YangDepartment of Neurology, Xinqiao Hospital and the Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Linyu LiDepartment of Neurology, Xinqiao Hospital and the Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Dongjing XieDepartment of Neurology, Xinqiao Hospital and the Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Nizhen YuDepartment of Neurology, Xinqiao Hospital and the Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Shihai YangDepartment of Neurology, Xinqiao Hospital and the Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Xiaolei ShiDepartment of Neurology, Xinqiao Hospital and the Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Dahong YangDepartment of Neurology, Xinqiao Hospital and the Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Fengli LiDepartment of Neurology, Xinqiao Hospital and the Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.ORCID 0000-0002-5899-9270
Qingwu YangDepartment of Neurology, Xinqiao Hospital and the Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.ORCID 0000-0002-2596-2631

Funding

Academic Excellence Program 2022XKRC003National Natural Science Foundation of China 82271349Talent Incubation Program 2022YQB011
6 · The paper itself

Abstract

objectiveThe impact of true first-pass effect (T-FPE, achieving substantial recanalization with extended thrombolysis in cerebral infarction; eTICI 3 after 1 thrombectomy) and outcomes on acute ischemic stroke (AIS) with large ischemic core remains uncertain. We aimed to study the association between T-FPE and outcomes in AIS patients with large core infarct through a real-world multicenter study.

methodsFrom a prospective multicentric registry, we collected the data of all consecutive acute stroke patients with a large ischemic core who underwent thrombectomy and compared the outcomes of patients who achieved T-FPE and those who did not. In addition, we compared the outcomes of patients with different numbers of thrombectomy pass to identify the effectiveness of T-FPE. Multivariate analysis was performed to determine the predictors of T-FPE. The primary outcome was good functional outcome (modified Rankin Scale score; mRS 0-3) at 90 days. Safety outcomes included a 90-day mortality and symptomatic intracerebral hemorrhage within 48 hours after thrombectomy.

resultsBetween November 2021 and February 2023, 447 eligible patients at 38 stroke centers were enrolled. Out of 447 thrombectomy patients, T-FPE was achieved in 102 individuals (22.8%). T-FPE was significantly associated with a higher proportion of good functional outcome (mRS 0-3 at 3 months, OR 2.221, 95% CI 1.418-3.479, p < 0.001) and lower mortality than non-T-FPE patients (31.4% vs. 45.5%, p = 0.012). The occlusion sites and lower DBP were strong predictors of T-FPE.

interpretationT-FPE was associated with favorable outcomes at 90 days in AIS patients with a large ischemic core who underwent EVT.

Indexed as

Ischemic StrokeRegistriesThrombectomyAgedAged, 80 and overFemaleHumansMaleMiddle AgedOutcome Assessment, Health CareProspective Studies

Identifiers

PMID39095680
PMCPMC11537132

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.